Ha Tay Pharmaceutical JSC

18
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DHT3
VND
68,800.00
-700 (-1.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
24,02,040.00
20,86,352.00
19,99,303.00
18,37,394.00
16,09,364.00
20,06,475.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
24,02,040.00
20,86,352.00
19,99,303.00
18,37,394.00
16,09,364.00
20,06,475.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
1,01,091.00
91,271.00
80,821.00
68,293.00
94,337.00
Operating Expenses
13,056.00
14,307.00
20,115.00
14,329.00
14,016.00
13,355.00
General and Administration Expenses
1,68,478.00
1,36,799.00
97,619.00
78,455.00
84,970.00
1,22,383.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
23,61,329.00
20,05,907.00
18,96,310.00
17,31,745.00
15,43,706.00
18,93,669.00
Operating Profit (PBDIT) excl Other Income
40,710.00
80,445.00
1,02,993.00
1,05,649.00
65,657.00
1,12,805.00
Other Income
45,654.00
33,016.00
31,242.00
35,102.00
41,460.00
21,291.00
Operating Profit (PBDIT)
1,10,509.00
1,30,009.00
1,47,536.00
1,55,001.00
1,20,181.00
1,43,971.00
Interest
13,056.00
14,307.00
20,115.00
14,329.00
14,016.00
13,355.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
24,143.00
20,480.00
17,077.00
17,448.00
16,651.00
13,259.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
73,309.00
95,221.00
1,10,343.00
1,23,223.00
89,512.00
1,20,535.00
Provision for Tax
14,269.00
20,027.00
21,382.00
24,259.00
18,122.00
24,427.00
Profit After Tax
53,656.00
71,771.00
85,055.00
95,211.00
67,945.00
92,047.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.00
792.41
1,529.08
1,170.61
841.84
1,131.71
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 15.13% vs 4.35% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -49.39% vs -21.89% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -8.74% vs -28.87% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is -25.24% vs -15.62% in Dec 2024

Compare Profit and Loss Results of Ha Tay Pharmaceutical JSC
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
No of Months
12
12
Operating Income
24,02,040.00
13,06,797.00
10,95,243.00
83.81%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
24,02,040.00
13,06,797.00
10,95,243.00
83.81%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
1,20,461.00
-1,20,461.00
-100.00%
Operating Expenses
13,056.00
25,494.00
-12,438.00
-48.79%
General and Administration Expenses
1,68,478.00
1,40,266.00
28,212.00
20.11%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
23,61,329.00
12,46,967.00
11,14,362.00
89.37%
Operating Profit (PBDIT) excl Other Income
40,710.00
59,830.00
-19,120.00
-31.96%
Other Income
45,654.00
34,441.00
11,213.00
32.56%
Operating Profit (PBDIT)
1,10,509.00
1,32,528.00
-22,019.00
-16.61%
Interest
13,056.00
25,494.00
-12,438.00
-48.79%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
24,143.00
38,257.00
-14,114.00
-36.89%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
73,309.00
68,776.00
4,533.00
6.59%
Provision for Tax
14,269.00
14,631.00
-362.00
-2.47%
Profit After Tax
53,656.00
53,571.00
85.00
0.16%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0
733.4384
-733.44
-100.00%
Profit And Loss - Net Sales
Net Sales 24,02,040.19 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 15.13% vs 4.35% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 40,710.87 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -49.39% vs -21.89% in Dec 2024

Profit And Loss - Interest
Interest 13,056.31 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -8.74% vs -28.87% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 53,656.83 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -25.24% vs -15.62% in Dec 2024